International Dna Testing Headlines
International consortium publishes third-generation map of human genetic variation
An international consortium today published a third-generation map of human genetic variation, called the HapMap, which includes data from an additional seven global populations, increasing the total number to 11 populations. The improved resolution will help researchers interpret current genome studies aimed at finding common and rarer genetic variants associated with complex diseases.
Read more...
Abbott gets US FDA nod for Abbott RealTime HBV assay, automated molecular test for assessing hep B treatment
Abbott has received approval from the US Food and Drug Administration (FDA) to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus (HBV) in a patient's blood.
Read more...
PerkinElmer Extends Services for Specialty Rx Lab Minerva
NEW YORK (GenomeWeb News) – PerkinElmer today announced it is extending its OneSource Laboratory Services contract with specialty pharmaceutical testing laboratory Minerva Scientific.
Read more...
Guidance for Mass Fatality DNA Identification Now Available
The Guidance document for Mass Fatality DNA Identification is now available on the AABB website for anyone interested in program management as well as technical issues in the DNA identification of mass fatality victims.
Read more...
Abbott Receives FDA Approval For First Automated Molecular Test For Assessing Hepatitis B Treatment
Abbott (NYSE: ABT) announced it has received approval from the U.S. Food and Drug Administration (FDA) to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus (HBV) in a patient's blood. It is the first and only approved test capable of automating HBV viral load testing from sample extraction to final results. The Abbott RealTime HBV assay, based on ...
Read more...
|